Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by macman1519on Jan 31, 2018 1:57pm
75 Views
Post# 27472628

RE:RE:RE:RE:Right to TRY

RE:RE:RE:RE:Right to TRY I just shake my head and laugh!!! Dont worry, be happy two years from now, we be good, mon!!!! Finances???? We no talk bout dat, mon!! Chill, have some ganga!!!! pp, no bad, more ganga, better it look, mon!! Chill, 6 months we bring pharma on board, but now???? Ganga an pp an ganga an we good, mon, we be good!!! Here have some more ganga, Jamaica, Bahamas, OOOOOOH I WANNA TAKE YAAAA!!!
Quattro74 wrote: Lazer I think we are well on our way, the market hasn't caught up yet with the science. That will change once we apply for the FDA phase 2, and again once they approve it. Looks like both will happen this year! Then 2019 will be about 'conditional nod' of approval and or phase 2 results and financing deals and patent approvals and additional phase 1s. Exciting stuff!

This really doesn't get serious until that FDA application and once the sp gets above .55c we will see the warrant money come in that will solve much of the financing.


Bullboard Posts